A detailed history of Haven Capital Group, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Haven Capital Group, Inc. holds 49,137 shares of EW stock, worth $4.24 Million. This represents 3.4% of its overall portfolio holdings.

Number of Shares
49,137
Previous 50,220 2.16%
Holding current value
$4.24 Million
Previous $3.93 Billion 2.72%
% of portfolio
3.4%
Previous 3.46%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$73.75 - $81.83 $79,871 - $88,621
-1,083 Reduced 2.16%
49,137 $3.82 Billion
Q2 2025

Aug 14, 2025

SELL
$67.07 - $78.22 $86,855 - $101,294
-1,295 Reduced 2.51%
50,220 $3.93 Billion
Q1 2025

May 15, 2025

SELL
$67.95 - $76.19 $51,913 - $58,209
-764 Reduced 1.46%
51,515 $3.73 Billion
Q4 2024

Feb 10, 2025

BUY
$64.54 - $75.92 $3.37 Million - $3.97 Million
52,279 New
52,279 $3.87 Billion

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $53.4B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Haven Capital Group, Inc. Portfolio

Follow Haven Capital Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Haven Capital Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Haven Capital Group, Inc. with notifications on news.